Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Kupfer im Fokus: Warum US-Projekte jetzt neu gelesen werden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

OMX Iceland 15 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im OMX Iceland 15

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
FrJanuarzahlen bei Icelandair: Mit Icelandair flogen im Berichtsmonat Januar 2026 insgesamt 300.377 Passagiere, ...2
FrIcelandair Q4 2025 presentation: record revenue offset by currency headwinds2
FrFesti hf.: Presentation of Q4 and 12M 2025 results2
FrIcelandair Group hf.: Strong demand to and from Iceland, with passenger numbers up by 14%77In January 2026, Icelandair transported 300 thousand passengers, 14% more than in January last year. Passenger distribution in January was as follows: 30% were traveling to Iceland, 21% from Iceland...
► Artikel lesen
DoIcelandair Group hf.: Financial results Q4 and 12M 20251.294 Record revenue in 2025 of USD 1.7 billion, up by 11% with a 17% increase in Q4 EBIT in 2025 was negative at USD 17.2 million, down by USD 3 million, but improving by USD 2.0 million in Q4 EBIT for...
► Artikel lesen
DoFesti hf.: 2025 Annual report291End of a strong year for Festi: Strong operational performance in the quarter and the results for the year significantly exceeded the company's initial guidance. Main results in Q4 2025 Sales of goods...
► Artikel lesen
DoAlvotech higher on positive data backing biosimilar to Takeda's Entyvio5
DoAlvotech - 6-K, Report of foreign issuer2
DoSyntholene Energy Corp: Syntholene Energy Corp Strengthens Advisory Board with Former COO of Icelandair Jens Thordarson254Chicago, Illinois--(Newsfile Corp. - February 5, 2026) - Syntholene Energy Corp. (TSXV: ESAF) (OTCQB: SYNTF) (FSE: 3DD0) ("Syntholene" or the "Company") announces the nomination of Jens Thordarson...
► Artikel lesen
DoAlvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio151The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio in healthy adult participants, met all its primary endpoints REYKJAVIK, Iceland...
► Artikel lesen
MoKvika banki hf.: Transaction in relation to a share buy-back programme2
MoAlvotech Enters Supply, Commercialization Deal With Sandoz Covering Biosimilar Candidates16
MoFesti hf.: Buyback program week 52
MoAlvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates132REYKJAVIK, Iceland, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide...
► Artikel lesen